Overview
Effects of Ulinastatin on Coagulation in High Risk Patients Undergoing Off Pump Coronary Artery Bypass Graft Surgery
Status:
Completed
Completed
Trial end date:
2011-05-01
2011-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Ulinastatin reduce the amount of bleeding and fibrinolysis in high risk patients undergoing off-pump coronary bypass surgery (OPCAB).Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Yonsei UniversityTreatments:
Pharmaceutical Solutions
Urinastatin
Criteria
Inclusion Criteria:- Eighty high risk patients undergoing OPCAB (High risk patients: Euro score ≥ 6 , acute
coronary syndrome, preoperative CK-MB increased over 5 times than normal value and
high sensitivity CRP ≥2.0)
Exclusion Criteria:
- The patients who receive additional operations, the patients who don't agree to
participate in this trial, the patients who has a past hypersensitive experience on
Ulinastatin